A South African pharmaceutical company is preparing a major clinical trial for an experimental oral Ebola treatment. Xylomed Pharmaceuticals plans to conduct the study in the Democratic Republic of Congo, Uganda and South Sudan. These countries have faced recurring outbreaks of the highly infectious disease. The double-blind, randomised clinical trial will assess whether the candidate medicine is safe and effective.…
Tag: Democratic Republic Of Congo
-
Ebola Treatment Trials Need Urgent $18m Funding
The Africa Centres for Disease Control and Prevention has called for urgent international funding to support experimental Ebola treatment trials in the Democratic Republic of Congo. Africa CDC said at least $18 million was needed immediately. It warned that funding delays could weaken efforts to contain the outbreak and lead to preventable deaths. Researchers are preparing to launch clinical trials…
-
Ebola Outbreak Raises Red Flag As Death Toll Climbs
Health authorities in the Democratic Republic of Congo (DRC) have reported 26 additional suspected Ebola deaths in 24 hours in the country’s east. The jump has heightened concern about how quickly the crisis is expanding. The reported total now stands at 131 deaths linked to the outbreak. Authorities have logged 516 suspected cases and 33 confirmed cases so far. The…